DelveInsight launched a new report on SPAIN Healthcare Outlook Report 2022.
DelveInsight’s, “Spain Healthcare Outlook Report, 2022,” report provides comprehensive insights about healthcare scenario, regulatory policies, and reimbursement landscape in Spain. The report also identifies key trends in the healthcare market and provides insights into the demographic and healthcare infrastructure of the country. Along with this the report also provides a brief look into the trends and segmentation of the pharmaceutical and medical devices market of Spain.
Request for a detailed sample copy of the report: https://www.delveinsight.com/sample-request/spain-healthcare-outlook-report
Spain Healthcare Outlook 2022
Spain officially the Republic of Spain, is a sovereign island city-state in maritime Southeast Asia with 46.45 million people, distributed on a territory of 505,990 square kilometers. GDP Growth Rate in Spain averaged 0.29 percent from 1995 until 2020, reaching an all-time high of 1.60 percent in the first quarter of 2000 and a record low of -18.50 percent in the second quarter of 2020. The Spanish National Healthcare System (“Instituto Nacional de la Salud”) founded on Spain’s General Healthcare Act of 1986, guarantees universal coverage and free healthcare access to all Spanish nationals, regardless of economic situation or participation in the social security network.
The National Health System – NHS – is comprised by both the Central Government Administration and the autonomous regions public healthcare managements working in coordination to cover all the healthcare duties and benefits for which public authorities are legally responsible.
Spain Industry Overview Chapter
Pharmaceutical
Farmaindustria is the National Trade Association of the Spanish based pharmaceutical industry. It gathers most of the R&D based pharmaceutical companies established in the country, representing nearly 100% of prescription medicines sales in Spain. The industry researches, develops, produces and markets pharmaceuticals which relieve maladies, and cures diseases. The economic contribution of the sector holds the highest productivity rate of the pharmaceutical industry; constitutes a source of qualified, stable and diverse employment with about $ 13.5 million worth of exports each year; it is also intensive in R&D (20% of the whole industrial sector). Besides, the pharmaceutical industry is committed with the digitalization of Spanish public biomedical research with the healthcare system in continued training and updating of the knowledge base of its professionals. Farmaindustria is organized around different work areas, with the aim of developing and executing its mission: Self-Regulation, Relations with autonomous regions, Economic Department, R&D, International Affairs Department, Legal Department, Patients and Healthcare Professionals and Technical Department. 20% of the R&D investment of Spanish industry is undertaken by the pharmaceutical sector.
Medical Device
Medical device can be classified according to the intended purpose of medical devices in general, active implantable medical devices and medical devices for in vitro diagnosis. The EC market and the adoption of quality standards ISO 9000 along with the transfer to domestic laws of the various European directives governing the sector allow the free movement of healthcare technology within the European Union. A key opportunity for foreign companies to come to manufacture and market their products, equipment, devices in Spain and supply the nearly 800 hospitals that make up the National Health System. To carry out and promote that development it is necessary to invest and expand coverage and infrastructure of the healthcare technology sector and commit to the subsectors that have more impact and relevance for this digitization process in the healthcare sector: the Technology Sector and Clinical Information Systems.
Apart from this the report covers some latest information on COVID 19 update and future of healthcare technology in Spain.
Key Players
- McKinsey Spain
- Anaconda BioMed
- Asphalion
- Droplite Technologies, S.L.
- GENESIS Biomed
- Histocell
- Institut de Bioenginyeria de Catalunya
- Instituto de Investigación e Innovación Parc Taulí
- Linear Chemicals, S.L.U.
- Transplant Biomedicals
- Universitat Autònoma de Barcelona (UAB)
- MICROPTIC S.L.
Click here and get access to free sample pages of the Spain Healthcare Outlook report.
Table of contents:
1. Key Insights
2. Spain at a Glance
3. Executive Summary
4. Assessment
5. Market Access
6. Spain PESTLE Analysis
7. Driver and Barriers
8. Appendix
9. References
10. DelveInsight Capabilities
11. Disclaimer
12. About DelveInsight
Download report: https://www.delveinsight.com/report-store/spain-healthcare-outlook-report
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/